Arcadia Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-221
| Closed | -$89.9K | – | 336 |
|
|
2023
Q4 | $89.9K | Hold |
221
| – | – | 0.02% | 172 |
|
|
2023
Q3 | $76.9K | Hold |
221
| – | – | 0.02% | 178 |
|
|
2023
Q2 | $77.8K | Buy |
+221
| New | +$77.8K | 0.02% | 189 |
|
|
2018
Q3 | – | Sell |
-160
| Closed | -$27K | – | 331 |
|
|
2018
Q2 | $27K | Hold |
160
| – | – | 0.01% | 267 |
|
|
2018
Q1 | $26K | Hold |
160
| – | – | 0.01% | 271 |
|
|
2017
Q4 | $24K | Hold |
160
| – | – | 0.01% | 284 |
|
|
2017
Q3 | $24K | Hold |
160
| – | – | 0.01% | 287 |
|
|
2017
Q2 | $21K | Hold |
160
| – | – | 0.01% | 288 |
|
|
2017
Q1 | $17K | Hold |
160
| – | – | 0.01% | 341 |
|
|
2016
Q4 | $12K | Hold |
160
| – | – | ﹤0.01% | 282 |
|
|
2016
Q3 | $14K | Hold |
160
| – | – | ﹤0.01% | 290 |
|
|
2016
Q2 | $14K | Hold |
160
| – | – | ﹤0.01% | 380 |
|
|
2016
Q1 | $13K | Hold |
160
| – | – | ﹤0.01% | 247 |
|
|
2015
Q4 | $20K | Buy |
+160
| New | +$20K | 0.01% | 221 |
|